Kinnera Swaroopa, Owasoyo Oluwaseyi, Rahim Hafiz Muhammad Zahid, Rahim Asma, Sunil Kashish Keswani, Chaudhary Prabhav, Rahim Uzma, Awan Abrar A
Acute Medicine, Royal Stoke University Hospital, Stoke-on-Trent, GBR.
Cureus. 2024 Nov 19;16(11):e73967. doi: 10.7759/cureus.73967. eCollection 2024 Nov.
Although parenteral iron is widely used to treat iron deficiency anemia (IDA), some side effects have been inadequately explored. Hypophosphatemia is becoming a well-documented, yet poorly understood, side effect of parenteral iron infusion, oftentimes causing serious and/or prolonged complications. In this article, we discuss the case of a 33-year-old female with IDA who suffered debilitating physical and mental symptoms of significant recurrent hypophosphatemia following a single standard dose of parenteral iron administration. Despite initial management with repeated parenteral and oral phosphate replacement, the hypophosphatemia, along with its symptoms and sequelae, persisted until active vitamin D supplementation with calcitriol was commenced following a multispecialty team decision. This case highlights the deficiencies in the recognition and management of parenteral iron-induced hypophosphatemia and proposes a requirement for standardization in its management strategies, including the use of vitamin D supplementation.
尽管胃肠外铁剂被广泛用于治疗缺铁性贫血(IDA),但其一些副作用尚未得到充分研究。低磷血症正成为一种有充分文献记载但了解不足的胃肠外铁剂输注副作用,常常会导致严重和/或长期并发症。在本文中,我们讨论了一名33岁患有IDA的女性病例,该患者在单次标准剂量胃肠外铁剂给药后出现严重反复低磷血症,导致身心衰弱症状。尽管最初采用重复胃肠外和口服补充磷酸盐进行治疗,但低磷血症及其症状和后遗症持续存在,直到多专科团队决定开始使用骨化三醇进行活性维生素D补充后才得以缓解。本病例突出了胃肠外铁剂诱导的低磷血症在识别和管理方面的不足,并提出了对其管理策略进行标准化的要求,包括使用维生素D补充剂。